New Member Spotlight: KlarBio

We warmly welcome KlarBio as a new member of our life science park, located in our coworking space in The Spark building! KlarBio connects market research with tactical marketing plans that help companies achieve their goals, by auditing their marketing strategy and tailoring a plan for faster growth with clear metrics, and more.

There will be an opportunity to meet KlarBio’s Founder and Managing Director, Avi Saha, on 17 March, when KlarBio hosts a Science for Breakfast at Medicon Village.

We asked Avi Saha, Founder and Managing Director, three key questions to highlight what makes them a trusted and versatile life science partner:

How can the life science community benefit from your membership at Medicon Village?

– By sharing insights into what marketing strategies work effectively for complex products, startups and scale-ups in this region can start their commercialization efforts on the right foot and launch products with more confidence using perfect English and creative strategies. Furthermore, KlarBio aims to strengthen the Nordic region by providing a base of marketing expertise more locally, whereas such services are often imported from abroad.

– I think what makes KlarBio unique is that the type of marketing I offer has much larger implications on sales. Most marketing agencies don’t do much marketing, they are advertising companies. True marketing happens when you build better products and make sure customer insights are continually gathered and acted upon. As a result, you discover your ideal customer much faster.

What makes KlarBio a unique and reliable partner?

– What makes KlarBio unique is the combination of creativity with scientific and business acumen. We have studied marketing and finance, worked with high-tech companies, and have advanced degrees. So we can have conversations with executives and ultimately get more done than a pure advertising agency.

– I believe what makes my approach unique is that although my title involves “marketing,” there is no specific role that would cover what I offer. The method I use optimizes how multiple roles within a company work together, so that the entire commercial team is more agile. The goal is to make sure the foundation for marketing is set so that growth is sustainable, measurable, and even reproducible. In other words, you should be able to launch a feature, or a campaign, or even write a LinkedIn post and have a rough idea of what impact it will have. This approach makes me a thought partner – someone who business leaders can consult with on a variety of issues. Since it takes 6-12 months to assess how a marketing strategy worked, long-term partnership is in fact ideal, as compared with delivering slides without

– It’s about providing as much value in a given situation as possible where it would fit in an organization – smack-dab in the middle of product, marketing, and sales. Unlike an advertising agency, which typically lacks customer insight, I believe We aren’t an advertising agency, like most life science marketing companies. brings experience from high-tech life science companies that sell directly to pharma and hospitals, from pre-discovery solutions to IVD products. This means that we understand the challenges involved with selling novel products to this market.

What challenges and opportunities do you see in the coming year?

– Speaking for TechBio companies, the main challenge is building a product that pharmaceutical customers can directly benefit from. We are seeing acquisitions of smaller, niche providers of analysis software for example, because they want to use this technology to create better medicines. A platform on its own can easily get replaced as features made by AI are becoming commodities.

– Therefore, to stand out, partnerships will continue to be a critical opportunity. By combining offerings with products in adjacent markets, one can offer something much greater than the sum of its parts. And as always, speaking less technically and proving value by diligently sharing data from internal studies or that with collaborators is going to differentiate a company’s claims from a sea of sameness.

– The same concept applies to challenges in life science marketing. Everyone is talking about AI but few are implementing AI into workflows that actually help. Telling a client to use a new piece of software isn’t helping, it’s hurting. For myself, the immediate thing to do is to find processes that deliver better results. In the long term, it’s leveraging AI to do what was truly impossible previously and that which eliminates a lot of manual effort. An example here is automatically updating documents with low-click or one-click workflows, which some call “synthetic” marketing.

– All of us marketers are trying to understand how to use AI better. The challenge however involves implementing it in an organization. Is it a single app one should use? Should one build customized workflows?

– With so many AI-based solutions out there for improving marketing, it’s not clear which tools one should subscribe to. Beyond that, for any consultant, it’s important to build processes that reduce headaches for the client, especially when it comes to reviewing material, tracking projects, and so on.

– Beyond that, the main challenge hasn’t changed: understanding why a business is different and who would benefit most from that. Most companies can serve a variety of markets, and have unexplored opportunities for growth because they lack the resources and labor to investigate further.

For more information on how KlarBio can support your next project, visit the KlarBio website.